Product Description:
Beacon Medicare Limited (BML) has launched new anti-cancer drugs in injection form under the brand name “Nivolunix,”.The medicine under the generic of Nivolumab INN is expected to accelerate cancer immunotherapy and will also be used in treating melanoma, lung, head and neck cancer, Hodgkin lymphoma and Hepatocellular carcinoma (HCC).
It is suggested for slow injection into vein of the patients suffering from such type of cancer only for export purpose.
Product Features:
| Product Name | : | Nivolunix |
| Generic Name | : | Nivolumab |
| Formulation | : | Injection |
| Available Pack Size | : | 1’s Vial |
| Available Strength | : | 100mg/10ml |
| Registrations | Available |
